Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Barak

Showing results (211-220 of 233) with videos related to

Pageof 24
Sort By:
Research Square|December 23, 2024
Design of allosteric modulators that change GPCR G protein subtype selectivityMadelyn N Moore, Kelsey L Person, Abigail Alwin, et al.
Scientific Reports|December 12, 2022
Establishment of multi-stage intravenous self-administration paradigms in miceLauren M Slosky, Andrea Pires, Yushi Bai, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 2017
Protamine is an antagonist of apelin receptor, and its activity is reversed by heparinSophie Le Gonidec, Carline Chaves-Almagro, Yushi Bai, et al.
Bioorganic & Medicinal Chemistry|July 5, 2017
Design, synthesis and biological evaluation of GPR55 agonistsLara Fakhouri, Christopher D Cook, Mohammed H Al-Huniti, et al.
Breast Cancer Research : BCR|June 9, 2012
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cellsXiu-Rong Ren, Junping Wei, Gangjun Lei, et al.
Nature|October 22, 2025
Designing allosteric modulators to change GPCR G protein subtype selectivityMadelyn N Moore, Kelsey L Person, Valeria L Robleto, et al.
Journal of Medicinal Chemistry|August 8, 2019
Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric ModulatorsAnthony B Pinkerton, Satyamaheshwar Peddibhotla, Fusayo Yamamoto, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Imidazole-derived agonists for the neurotensin 1 receptorPaul M Hershberger, Michael P Hedrick, Satyamaheshwar Peddibhotla, et al.
Molecular Pharmacology|September 10, 2010
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activityPingwei Zhao, Haleli Sharir, Ankur Kapur, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2016
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-onesMaria Elena Meza-Aviña, Mary A Lingerfelt, Linda M Console-Bram, et al.
Pageof 24

Showing results (211-220 of 233) with videos related to

Sort By:
Pageof 24
Research Square|December 23, 2024
Design of allosteric modulators that change GPCR G protein subtype selectivityMadelyn N Moore, Kelsey L Person, Abigail Alwin, et al.
Scientific Reports|December 12, 2022
Establishment of multi-stage intravenous self-administration paradigms in miceLauren M Slosky, Andrea Pires, Yushi Bai, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 2017
Protamine is an antagonist of apelin receptor, and its activity is reversed by heparinSophie Le Gonidec, Carline Chaves-Almagro, Yushi Bai, et al.
Bioorganic & Medicinal Chemistry|July 5, 2017
Design, synthesis and biological evaluation of GPR55 agonistsLara Fakhouri, Christopher D Cook, Mohammed H Al-Huniti, et al.
Breast Cancer Research : BCR|June 9, 2012
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cellsXiu-Rong Ren, Junping Wei, Gangjun Lei, et al.
Nature|October 22, 2025
Designing allosteric modulators to change GPCR G protein subtype selectivityMadelyn N Moore, Kelsey L Person, Valeria L Robleto, et al.
Journal of Medicinal Chemistry|August 8, 2019
Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric ModulatorsAnthony B Pinkerton, Satyamaheshwar Peddibhotla, Fusayo Yamamoto, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Imidazole-derived agonists for the neurotensin 1 receptorPaul M Hershberger, Michael P Hedrick, Satyamaheshwar Peddibhotla, et al.
Molecular Pharmacology|September 10, 2010
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activityPingwei Zhao, Haleli Sharir, Ankur Kapur, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2016
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-onesMaria Elena Meza-Aviña, Mary A Lingerfelt, Linda M Console-Bram, et al.
Pageof 24